Canada markets closed

Obalon Therapeutics, Inc. (OBLN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9100+0.0273 (+3.09%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 57.04M
Enterprise Value 3822.05k
Trailing P/E N/A
Forward P/E 1-3.37
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.70
Price/Book (mrq)0.98
Enterprise Value/Revenue 30.32
Enterprise Value/EBITDA 6-0.05

Trading Information

Stock Price History

Beta (5Y Monthly) -0.86
52-Week Change 3-57.87%
S&P500 52-Week Change 312.20%
52 Week High 32.3200
52 Week Low 30.6200
50-Day Moving Average 30.8003
200-Day Moving Average 30.8418

Share Statistics

Avg Vol (3 month) 3381.4k
Avg Vol (10 day) 3171.22k
Shares Outstanding 57.73M
Float 6.6M
% Held by Insiders 14.12%
% Held by Institutions 128.05%
Shares Short (Aug. 30, 2020) 4330.39k
Short Ratio (Aug. 30, 2020) 40.82
Short % of Float (Aug. 30, 2020) 45.20%
Short % of Shares Outstanding (Aug. 30, 2020) 44.27%
Shares Short (prior month Jul. 30, 2020) 4333.35k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul. 24, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-635.00%

Management Effectiveness

Return on Assets (ttm)-62.47%
Return on Equity (ttm)-232.16%

Income Statement

Revenue (ttm)2.6M
Revenue Per Share (ttm)0.36
Quarterly Revenue Growth (yoy)82.10%
Gross Profit (ttm)384k
EBITDA -16.12M
Net Income Avi to Common (ttm)-18.07M
Diluted EPS (ttm)-2.4680
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.8M
Total Cash Per Share (mrq)0.88
Total Debt (mrq)1.68M
Total Debt/Equity (mrq)23.33
Current Ratio (mrq)1.92
Book Value Per Share (mrq)0.93

Cash Flow Statement

Operating Cash Flow (ttm)-16.43M
Levered Free Cash Flow (ttm)-7.7M